US Stock MarketDetailed Quotes

PCSA Processa Pharmaceuticals

Watchlist

1.4800
-0.1000-6.33%

Close May 31 16:00 ET

1.4900
+0.0100+0.68%

Post 19:02 ET

4.23MMarket Cap-244P/E (TTM)

Processa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-31.57%2.81M

-43.44%11.46M

-57.42%2.47M

-64.21%2.17M

-47.51%2.71M

27.16%4.11M

75.13%20.26M

72.15%5.8M

97.91%6.06M

75.66%5.17M

Selling and administrative expenses

-48.73%1.27M

-35.44%5.66M

-56.25%1.15M

-65.21%1.02M

-49.55%1.03M

109.17%2.48M

86.89%8.76M

102.29%2.63M

118.24%2.92M

53.06%2.03M

-General and administrative expense

-48.73%1.27M

-35.44%5.66M

-56.25%1.15M

-65.21%1.02M

-49.55%1.03M

109.17%2.48M

86.89%8.76M

102.29%2.63M

118.24%2.92M

53.06%2.03M

Research and development costs

-5.43%1.54M

-49.54%5.8M

-58.39%1.32M

-63.28%1.15M

-46.19%1.69M

-20.38%1.63M

67.12%11.49M

53.26%3.17M

82.12%3.14M

94.27%3.14M

Operating profit

31.57%-2.81M

43.44%-11.46M

57.42%-2.47M

64.21%-2.17M

47.51%-2.71M

-27.16%-4.11M

-75.13%-20.26M

-72.15%-5.8M

-97.91%-6.06M

-75.66%-5.17M

Net non-operating interest income expense

-0.29%83.22K

231.56%335.54K

16.19%64.52K

133.36%85.66K

1,278.38%102K

5,172.39%83.46K

770.41%101.2K

1,503.06%55.53K

1,972.73%36.71K

307.94%7.4K

Non-operating interest income

-0.29%83.22K

231.56%335.54K

16.19%64.52K

133.36%85.66K

1,278.38%102K

5,172.39%83.46K

770.41%101.2K

1,503.06%55.53K

1,972.73%36.71K

307.94%7.4K

Other net income (expense)

-1,704.35%-7.27M

Special income (charges)

----

--0

----

-1,704.35%-7.27M

----

-Less:Impairment of capital assets

----

--0

----

--7.27M

----

Income before tax

32.21%-2.73M

59.45%-11.12M

81.52%-2.4M

65.42%-2.08M

49.41%-2.61M

-24.63%-4.02M

-129.34%-27.42M

-286.63%-13.01M

-93.60%-6.02M

-56.77%-5.16M

Income tax

Net income

32.21%-2.73M

59.45%-11.12M

81.52%-2.4M

65.42%-2.08M

49.41%-2.61M

-24.63%-4.02M

-139.98%-27.42M

-308.70%-13.01M

-101.54%-6.02M

-63.58%-5.16M

Net income continuous Operations

32.21%-2.73M

59.45%-11.12M

81.52%-2.4M

65.42%-2.08M

49.41%-2.61M

-24.63%-4.02M

-139.98%-27.42M

-308.70%-13.01M

-101.54%-6.02M

-63.58%-5.16M

Minority interest income

Net income attributable to the parent company

32.21%-2.73M

59.45%-11.12M

81.52%-2.4M

65.42%-2.08M

49.41%-2.61M

-24.63%-4.02M

-139.98%-27.42M

-308.70%-13.01M

-101.54%-6.02M

-63.58%-5.16M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

32.21%-2.73M

59.45%-11.12M

81.52%-2.4M

65.42%-2.08M

49.41%-2.61M

-24.63%-4.02M

-139.98%-27.42M

-308.70%-13.01M

-101.54%-6.02M

-63.58%-5.16M

Basic earnings per share

68.56%-1.11

75.10%-8.48

89.53%-1.68

78.38%-1.6

68.75%-2

11.75%-3.53

-127.00%-34.05

-282.14%-16.05

-94.74%-7.4

-60.00%-6.4

Diluted earnings per share

68.56%-1.11

75.10%-8.48

89.53%-1.68

78.38%-1.6

68.75%-2

11.75%-3.53

-127.00%-34.05

-282.14%-16.05

-94.74%-7.4

-60.00%-6.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-31.57%2.81M	-43.44%11.46M	-57.42%2.47M	-64.21%2.17M	-47.51%2.71M	27.16%4.11M	75.13%20.26M	72.15%5.8M	97.91%6.06M	75.66%5.17M
Selling and administrative expenses	-48.73%1.27M	-35.44%5.66M	-56.25%1.15M	-65.21%1.02M	-49.55%1.03M	109.17%2.48M	86.89%8.76M	102.29%2.63M	118.24%2.92M	53.06%2.03M
-General and administrative expense	-48.73%1.27M	-35.44%5.66M	-56.25%1.15M	-65.21%1.02M	-49.55%1.03M	109.17%2.48M	86.89%8.76M	102.29%2.63M	118.24%2.92M	53.06%2.03M
Research and development costs	-5.43%1.54M	-49.54%5.8M	-58.39%1.32M	-63.28%1.15M	-46.19%1.69M	-20.38%1.63M	67.12%11.49M	53.26%3.17M	82.12%3.14M	94.27%3.14M
Operating profit	31.57%-2.81M	43.44%-11.46M	57.42%-2.47M	64.21%-2.17M	47.51%-2.71M	-27.16%-4.11M	-75.13%-20.26M	-72.15%-5.8M	-97.91%-6.06M	-75.66%-5.17M
Net non-operating interest income expense	-0.29%83.22K	231.56%335.54K	16.19%64.52K	133.36%85.66K	1,278.38%102K	5,172.39%83.46K	770.41%101.2K	1,503.06%55.53K	1,972.73%36.71K	307.94%7.4K
Non-operating interest income	-0.29%83.22K	231.56%335.54K	16.19%64.52K	133.36%85.66K	1,278.38%102K	5,172.39%83.46K	770.41%101.2K	1,503.06%55.53K	1,972.73%36.71K	307.94%7.4K
Other net income (expense)							-1,704.35%-7.27M
Special income (charges)	----	--0	----	----	----	----	-1,704.35%-7.27M	----	----	----
-Less:Impairment of capital assets	----	--0	----	----	----	----	--7.27M	----	----	----
Income before tax	32.21%-2.73M	59.45%-11.12M	81.52%-2.4M	65.42%-2.08M	49.41%-2.61M	-24.63%-4.02M	-129.34%-27.42M	-286.63%-13.01M	-93.60%-6.02M	-56.77%-5.16M
Income tax		0			0		0			0
Net income	32.21%-2.73M	59.45%-11.12M	81.52%-2.4M	65.42%-2.08M	49.41%-2.61M	-24.63%-4.02M	-139.98%-27.42M	-308.70%-13.01M	-101.54%-6.02M	-63.58%-5.16M
Net income continuous Operations	32.21%-2.73M	59.45%-11.12M	81.52%-2.4M	65.42%-2.08M	49.41%-2.61M	-24.63%-4.02M	-139.98%-27.42M	-308.70%-13.01M	-101.54%-6.02M	-63.58%-5.16M
Minority interest income
Net income attributable to the parent company	32.21%-2.73M	59.45%-11.12M	81.52%-2.4M	65.42%-2.08M	49.41%-2.61M	-24.63%-4.02M	-139.98%-27.42M	-308.70%-13.01M	-101.54%-6.02M	-63.58%-5.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	32.21%-2.73M	59.45%-11.12M	81.52%-2.4M	65.42%-2.08M	49.41%-2.61M	-24.63%-4.02M	-139.98%-27.42M	-308.70%-13.01M	-101.54%-6.02M	-63.58%-5.16M
Basic earnings per share	68.56%-1.11	75.10%-8.48	89.53%-1.68	78.38%-1.6	68.75%-2	11.75%-3.53	-127.00%-34.05	-282.14%-16.05	-94.74%-7.4	-60.00%-6.4
Diluted earnings per share	68.56%-1.11	75.10%-8.48	89.53%-1.68	78.38%-1.6	68.75%-2	11.75%-3.53	-127.00%-34.05	-282.14%-16.05	-94.74%-7.4	-60.00%-6.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall